Omeros Corporation - Common Stock (NQ:OMER)

18.61 +0.14 (+0.76%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omeros Corporation - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 16, 2023

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

Via Benzinga

Nasdaq Gains 1%; Charles Schwab Earnings Top Views ↗

October 16, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 1.02% to 34,012.79 while the NASDAQ rose 1% to 13,541.79. The S&P...

Via Benzinga

Topics Stocks

Why Omeros Corporation (OMER) Shares Are Nosediving ↗

October 16, 2023

Omeros Corp (NASDAQ: OMER) shares are trading lower by 47% to $1.20 during Monday's pre-market session.

Via Benzinga

Earnings Preview: Omeros ↗

August 08, 2023

Via Benzinga

Why Shares of Omeros Dropped on Monday ↗

June 12, 2023

The clinical-stage biopharmaceutical released trials data through a presentation.

Via The Motley Fool

Dow Surges Over 200 Points; Empire State Manufacturing Index Falls In October ↗

October 16, 2023

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.72% to 33,913.22 while the NASDAQ rose 0.46% to 13,468.82. The S&P 500 also...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 16, 2023

Via Benzinga

Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy

October 16, 2023

From Omeros Corporation

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 27, 2023

Via Benzinga

Omeros: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Earnings Preview: Omeros ↗

May 08, 2023

Via Benzinga

Omeros's Earnings: A Preview ↗

March 10, 2023

Via Benzinga

Omeros Corporation Reports Second Quarter 2023 Financial Results

August 09, 2023

From Omeros Corporation

Via Business Wire

Omeros Corporation to Announce Second Quarter Financial Results on Morning of August 9, 2023

August 04, 2023

From Omeros Corporation

Via Business Wire

Omeros Announces Webcast Details for Annual Meeting of Shareholders

June 21, 2023

From Omeros Corporation

Via Business Wire

Nasdaq, Methanex And Other Big Stocks Moving Lower On Monday ↗

June 12, 2023

U.S. stocks traded higher, with the Nasdaq Composite rising around 70 points on Monday. Here are some big stocks recording losses in today’s session. Beneficient (NASDAQ: BENF) shares fell 17% to...

Via Benzinga

Why Omeros Stock Bolted Higher This Week ↗

February 09, 2023

A $200 million milestone payment sparked a rally in the biopharma's shares this week.

Via The Motley Fool

Omeros Corporation Announces Availability on Its Website of Materials Accompanying Presentations of OMS906 Data at the 2023 European Hematology Association Congress

June 12, 2023

From Omeros Corporation

Via Business Wire

Omeros Corporation Announces Late-Breaking Presentation of OMS906 Data at the 2023 European Hematology Association (EHA) Congress

June 01, 2023

From Omeros Corporation

Via Business Wire

Omeros Corporation Reports First Quarter 2023 Financial Results

May 09, 2023

From Omeros Corporation

Via Business Wire

Omeros Corporation to Announce First Quarter Financial Results on May 9, 2023

May 04, 2023

From Omeros Corporation

Via Business Wire

Omeros Corporation Reports Interim Data with Alternative Pathway Inhibitor OMS906 as Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria

April 25, 2023

From Omeros Corporation

Via Business Wire

North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry

April 18, 2023

EQNX::TICKER_START (NASDAQ:CELH),(NASDAQ:OMER),(NYSE:MRK),(NASDAQ:RXDX) EQNX::TICKER_END

Via FinancialNewsMedia

Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 20, 2023

Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market...

Via Benzinga

Omeros Corporation Awarded $6.69 Million Grant from the National Institute on Drug Abuse for its OMS527 Addiction Program

April 10, 2023

From Omeros Corporation

Via Business Wire

Short Interest Sector Focus: Healthcare Sector ↗

April 04, 2023

As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

Omeros Corporation Reports Fourth Quarter and Year-End 2022 Financial Results

March 13, 2023

From Omeros Corporation

Via Business Wire

Omeros Corporation Confirms Absence of Financial Exposure to Silicon Valley Bank

March 10, 2023

From Omeros Corporation

Via Business Wire

Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023

March 07, 2023

From Omeros Corporation

Via Business Wire

Why Bed Bath & Beyond Fell Almost 30%; Here Are 20 Stocks Moving Premarket ↗

February 07, 2023

Gainers

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.